As communicated previously, the inclusion of patients in the NEX-18 study has been paused due to moderate skin reactions at the injection site, and an investigation has been initiated to clarify the cause. The investigation is carried out in collaboration with the clinics in the study and is expected to be concluded during the fourth quarter 2021.
To make sure that the NEX-18 project proceeds in the most optimal way,
“We are doing these complementary preclinical studies in pigs in order to get a clear understanding of what caused the skin reactions and how we could minimize local skin reactions in connection with NEX-18 administration,” said
© Modular Finance, source